Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenshenyangxue is a traditional Chinese medicine (TCM) formulation used primarily in the management of gynecological disorders, notably polycystic ovary syndrome (PCOS). The name "wenshenyangxue" translates to "warming the kidney and nourishing blood," reflecting its TCM therapeutic principles. It is typically composed of a combination of herbal ingredients designed to tonify kidney yang and enrich blood, aiming to restore hormonal balance and improve reproductive function. Its mechanism of action is based on TCM theory rather than modern pharmacology; thus, specific molecular targets are not defined in Western biomedical terms. Clinical studies have observed its use as part of integrative therapy for PCOS[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wenshenyangxue.